[
    [
        {
            "time": "",
            "original_text": "【智飞生物|年报点评】2019年业绩符合预期，重磅品种即将获批上市【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "业绩",
                    "重磅品种",
                    "获批上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【智飞生物|年报点评】2019年业绩符合预期，重磅品种即将获批上市【安信医药马帅团队】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "渝股点金｜智飞生物：年报净利同比大幅 近期持续强势",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "净利",
                    "同比",
                    "大幅增长",
                    "近期强势"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渝股点金｜智飞生物：年报净利同比大幅 近期持续强势",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "鹰眼预警:智飞生物毛利率净利率双降 应收存货占比高 盈利能力下降",
            "features": {
                "keywords": [
                    "智飞生物",
                    "毛利率",
                    "净利率",
                    "双降",
                    "应收存货",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "鹰眼预警:智飞生物毛利率净利率双降 应收存货占比高 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物2019年营收突破百亿元大关",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2019年",
                    "营收",
                    "突破",
                    "百亿元大关"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物2019年营收突破百亿元大关",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物2019年营收同比翻倍 九价HPV疫苗批签发量同比增长173.35%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2019年",
                    "营收",
                    "同比翻倍",
                    "九价HPV疫苗",
                    "批签发量",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物2019年营收同比翻倍 九价HPV疫苗批签发量同比增长173.35%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：业绩持续高增长，重磅产品进入密集收获期",
            "features": {
                "keywords": [
                    "智飞生物",
                    "业绩",
                    "高增长",
                    "重磅产品",
                    "密集收获期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：业绩持续高增长，重磅产品进入密集收获期",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "渝股看台｜智飞生物去年净赚23亿 多项疫苗取得进展",
            "features": {
                "keywords": [
                    "智飞生物",
                    "去年",
                    "净赚",
                    "23亿",
                    "多项疫苗",
                    "取得进展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渝股看台｜智飞生物去年净赚23亿 多项疫苗取得进展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]